Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs placebo in treatment-resistant depression (double-blind RCT with open-label extension)
jRCTs031210124Completed
- Sponsor
- Takeda Science Foundation
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in treatment-resistant depression (TRD) comparing Ketamine with Placebo (2 arms). Primary endpoint: MADRS total score. Started May 2021; status: completed.
02
Drugs
ketamine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on jRCTs031210124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210124.